Pharmaceutical company recalls injectable medication due to contamination

American Regent has initiated a nationwide recall of one lot of Papaverine Hydrochloride Injection. The recall is due to the presence of visible particulate matter in the injectable product, which poses potential risks such as tissue irritation or blood vessel blockage. This action aims to prevent adverse patient outcomes and ensure drug safety.